Corbus Pharmaceuticals

CRBPNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$144.673 M

$7.48 +3.03%

Close of 18 Sept 2026

Revenue

—

Not reported

Earnings

-$78.5M

Loss-making

Shares outstanding

19,341,293

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#285Korro BioKRRO$147.6M
#286ImmunicIMUX$144.9M
#287Corbus PharmaceuticalsCRBP$144.7M
#288NRX PharmaceuticalsNRXP$143.7M
#289ADC TherapeuticsADCT$134.1M

Insiders buying

All insider buying →

One open-market purchase by officers and directors of Corbus Pharmaceuticals, worth $25.0K. Grants and option exercises are excluded.

Nishant C. SaxenaChief Business Officer$25.0K
2,600 shares at $9.63 on 11 Aug 2026 · filed 12 Aug 2026

What if Corbus Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $30.4T

$1,571,118

Per share 210,043× higher

Bitcoin $1.64T

$84,587.31

Per share 11,308× higher

Nvidia $5.36T

$276,957.03

Per share 37,026× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for Corbus Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 19 Sept 2026. Read the methodology.